Literature DB >> 11592602

Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment.

A Gervais1, M Martinot, N Boyer, A Auperin, W Le Breton, C Degott, D Valla, P Marcellin.   

Abstract

BACKGROUND/AIMS: To determine the correlation between hepatic hepatitis C virus (HCV) RNA and histological lesions, viral genotype or response to alpha interferon therapy.
METHODS: Forty-three patients with chronic hepatitis C (14 sustained responders (SR) and 29 non-sustained responders (NSR)) were studied. A liver tissue sample was obtained before and 1 year after treatment. Quantitation of hepatic HCV-RNA was performed by competitive PCR.
RESULTS: Before treatment, HCV-RNA was detectable in all liver samples. There was no association between hepatic HCV-RNA and the severity of liver lesions. There was a significant association between old age and hepatic HCV-RNA (P = 0.03). There was an association, at the limit of significance, between genotype 1 and high hepatic HCV-RNA amounts (15 x 106 and 4.1 x 10(6) copies/g, P = 0.05). Pre-treatment hepatic HCV-RNA amounts were lower in SRs than in others (0.65 x 10(6) and 13.2 x 10(6) copies/g, P = 0.0002). After treatment, no liver HCV-RNA was detectable in the SRs while in the NSRs, the HCV-RNA amounts were unchanged.
CONCLUSIONS: The amount of hepatic HCV-RNA is correlated to genotype and response to interferon therapy but not to histologic lesions. Hepatic HCV-RNA clearance is observed in SRs, suggesting viral eradication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592602     DOI: 10.1016/s0168-8278(01)00138-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  Randomised Trial of Two Different Daily Doses of Interferon-α versus Classical Therapy in Treatment-Naïve Patients with Chronic Hepatitis C.

Authors:  G Montalto; S Tripi; O Vuturo; G Di Gaetano; M Soresi; A Spadaro; A Aiello; M Russello; R Benigno; R Siciliano
Journal:  Clin Drug Investig       Date:  2002-09       Impact factor: 2.859

2.  Serum Serotonin Levels are Associated with Antiviral Therapy Outcomes in Patients with Chronic Hepatitis C.

Authors:  Jennifer M Loftis; Benjamin J Morasco; Daniel Menasco; Dietmar Fuchs; Max Strater; Peter Hauser
Journal:  Open Infect Dis J       Date:  2010-01-01

3.  Percentage of hepatitis C virus-infected hepatocytes is a better predictor of response than serum viremia levels.

Authors:  Elena Rodríguez-Iñigo; Juan Manuel López-Alcorocho; Javier Bartolomé; Nuria Ortiz-Movilla; Margarita Pardo; Vicente Carreño
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

4.  Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs.

Authors:  Milena Furione; Renato Maserati; Marta Gatti; Fausto Baldanti; Agostino Cividini; Raffaele Bruno; Giuseppe Gerna; Mario U Mondelli
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

5.  Variable ratio of hepatitis C virus RNA to viral core antigen in patient sera.

Authors:  Christian G Schüttler; Christine Thomas; Thomas Discher; Georg Friese; Jürgen Lohmeyer; Ralph Schuster; Stephan Schaefer; Wolfram H Gerlich
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

Review 6.  Natural History of Hepatitis C.

Authors:  Shilpa Lingala; Marc G Ghany
Journal:  Gastroenterol Clin North Am       Date:  2015-08-25       Impact factor: 3.806

7.  Determination of hepatitis C genotypes and the viral titer distribution in children and adolescents with major thalassemia.

Authors:  Touran Shahraki; Mansour Shahraki; Esmaiel Sanei Moghaddam; Mehri Najafi; Ali Bahari
Journal:  Iran J Pediatr       Date:  2010-03       Impact factor: 0.364

8.  Interrelationship of hepatitis C virus genotypes with patient characteristics in Bahrain.

Authors:  Maheeba A Abdulla; Eman A Murad; Hend A Aljenaidi; Duha R Aljowder; Omar Ik Aljeeran; Eman Farid; Jehad R Al Qamish
Journal:  Hepat Med       Date:  2017-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.